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Abstract
The pathophysiology of thoracic aortic aneurysm and dissection is poorly understood, 
despite high mortality. An evidence review was conducted to examine the biomechanical, 
chemical and genetic factors involved in thoracic aortic pathology. The composition of 
connective tissue and smooth muscle cells can mediate important mechanical properties 
that allow the thoracic aorta to withstand and transmit pressures. Genetic syndromes can 
affect connective tissue and signalling proteins that interrupt smooth muscle function, 
leading to tissue failure. There are complex interplaying factors that maintain thoracic 
aortic function in health and are disrupted in disease, signifying an area for  
extensive research.
Introduction
Thoracic aortic aneurysms and dissections (TAAD) are 
relatively less common when compared with other 
cardiovascular diseases, but can result in significant 
mortality and morbidity if managed inappropriately (1). 
Mortality of untreated dissections can approach 50% if no 
intervention is initiated within 48 hours (2). Aneurysms 
can be classified according to type (saccularor fusiform) 
and location (thoracic, thoracoabdominal or abdominal). 
They can lead to rupture or dissection - however, it is 
important to note that the majority of dissections do not 
have a pre-existing aneurysm (3). There is a wide spectrum 
of thoracic aortic aneurysmal disease, r summarised 
in Table 1. 
Thoracic aortic aneurysms (TAA) may show significant 
variation in rate of growth and flow dynamics. There are 
several hypotheses suggested for this difference, ranging 
from embryonic origin to modelling of collagen (4). The 
risk factors that govern development of aneurysms and 
dissections are multifactorial, including hypertension and 
several genetic conditions. The pathophysiology of TAAD 
is poorly understood and attributed to several influences, 
involving a complex interplay between mechanical forces 
exerted by biological structure in the healthy and diseased 
thoracic aorta.
This literature review will explore evidence 
surrounding the genetic, biological and mechanical aspects 
of the thoracic aorta in health and disease to provide an 
understanding of how these factors may influence the 
development of TAAD. Deeper understanding of this 
area could guide more comprehensive models of risk 
stratification, enhance programmes for early detection 
and inform clinical decision-making.
Biology of the thoracic aorta
The thoracic aorta is a composite tube encompassing 
three distinct layers: the intima, media, and adventitia, as 
illustrated in Fig. 1 (5). The intima lines the lumen of the 
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that is anchored to the underlying basement membrane 
(6). Endothelial cells are responsible for producing 
signals to control vessel tone and produce enzymes that 
are important for immune function, blood clotting and 
platelet adhesion (7). The basement membrane of the 
tunica intima is a highly specialised extra cellular matrix 
network consisting primarily of collagen type IV, laminin, 
perlecan and heparan sulphate proteoglycan (8).
The tunica media mainly consists of elastin lamellae 
and smooth muscle cells and its role is to provide elasticity 
to the thoracic aorta (9). Elastin lamellae are networks of 
cross-linked elastin fibres which provide elastic energy 
storage for the vessel (10). Elastin fibres mainly consist 
of elastin and have various other microfibrillar proteins 
incorporated into the fibre (10). A notable microfibrillar 
protein is fibrillin, which interacts with other proteins 
to aid assembly, function, and long-term stability of the 
elastic fibres (10). Smooth muscle cells induce vasodilation 
and constriction. Heterogenous origins of smooth muscle 
cells have recently been reported in the thoracic aorta and 
provide a better insight into the variable susceptibilities 
to disease in different parts of the aorta. Sawada  et  al. 
demonstrated the different origin of smooth muscles cells 
between the ascending and descending thoracic aorta 
using genetically modified mice(11). Furthermore, the 
inner medial smooth muscle cells of the ascending aorta 
are derived from the second heart field while the outer 
medial cells are derived from cardiac neural crest (11). 
Conversely, the smooth muscle cells of the descending 
aorta are derived from single origin of somites, which are 
formed from the paraxial mesoderm (11). This could help 
explain the increased susceptibility to aneurysm in the 
ascending aorta compared to the descending aorta (12). 
However, actual functional differences due to the different 
origin warrant further research. The thickness of the tunica 
media is greatest in the thoracic aorta and decreases along 
the vessel. This is because elastin is greatest in the thoracic 
aorta and decreases further along distally from the heart, 
as a greater elastic energy storage is required to counter 
the stronger pulse closer to the heart (13). Therefore, 
the thoracic aorta is more susceptible to defects in 
extracellular matrix synthesis compared to distal regions 
of the aorta. The wall thickness-to-lumen diameter ratio 
remains constant as the lumen also decreases in diameter 
along the aorta (6).
The adventitia mainly comprises of fibroblasts, 
fibrocytes and bundles of collagen, which are supported 
by an external elastic lamina and together provide tensile 
strength. The vasa vasorum is woven into the adventitia 
and supplies oxygen and nutrients to the outer regions 
of the thoracic aorta. Recent evidence has suggested that 
the vasa vasorum of the thoracic aorta penetrates much 
deeper into the vessel wall compared to the distal aorta. 
Tonar  et  al. demonstrated the vasa vasorum density 
is higher in the tunica media and penetrates deeper 
towards the lumen in the thoracic aorta as compared to 
the abdominal aorta in porcine tissue (14). Furthermore, 
Federspiel et al. used immunohistochemical staining and 
confirmed these findings in human thoracic aorta (15). 
Collagen primarily provides tensile strength and in the 
adventitia collagen types I and III predominate (16). 
Table 1 Spectrum of thoracic aortic aneurysmal disease.
Forms of TAA Characteristics Examples 
Degenerative Most common form of TAA
Weakening of connective tissue and tunica 
media 
Includes cystic medial necrosis and elastin 
degradation
Genetic syndrome Defects in elastin and collagen lead to 
maladaptive responses to increased wall stress
Marfan’s syndrome, vascular Ehler’s Danlos syndrome, 
Loey–Dietz syndrome, multisystemic smooth muscle 
dysfunction syndrome, Turner syndrome
Nonsyndromic Single gene mutations that lead to defective 
production and function of vascular 
endothelial cells or smooth muscle cells 
FBN1, FOXE3
Associations with bicuspid 
aortic valve disease
Leads to turbulent flow across it 
Leads to dilation of the aortic root and 
subsequent aneurysm formation
Figure 1
Layers of the thoracic aorta.
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Collagen is arranged in a circumferential alignment, so 
that the unstressed tissues of collagen fibres are embedded 
in a wavy form in the soft ground matrix (16). Tensile 
strength makes the adventitia less stiff than the media, 
preventing overstretching and rupture (16).
All three layers create a dynamic vessel capable of 
withstanding large hemodynamic forces, which are most 
prominent in the thoracic aorta. Emerging evidence has 
suggested that the cells of the thoracic aorta are plastic and 
able to transform into other types of cells. Sandison et al. 
used prolonged time-lapse imaging to illustrate that 
vascular smooth muscle cells (VSMC) transitioned into 
non-contractile migratory macrophage-like cells (17). This 
could aid the understanding of certain pathology in the 
thoracic aorta which will be discussed later in the review. 
Chemical pathways underlying thoracic 
aortic physiology
The smooth muscle cell contractile unit is composed of 
actin-containing thin filament and myosin thick filaments, 
along with regulatory proteins such as tropomyosin. The 
actin of the thin filament is a smooth muscle specific 
isoform which is encoded by the ACTA2 gene (18). The 
thick filament consists of a hexametric molecule composed 
of two myosin heavy chains, two essential light chains 
and two regulatory light chains. Smooth muscle cells 
contract mainly due to an increase in intracellular Ca2+ 
which is induced by neural, hormonal, and local factors 
(18). Intracellular Ca2+ binds to the protein Calmodulin 
forming a complex, which in turn binds to myosin light 
chain kinase to activate it (18). Active myosin light chain 
kinase phosphorylates the regulatory light chain of the 
myosin complex, which activates the actin-dependent 
ATPase activity of the myosin globular motor head and 
results in contraction (18). VSMC is mainly initiated by 
a decrease in intracellular Ca2+, which dissociates the 
Ca2+/Calmodulin complexes. However, this does not 
result in complete relaxation and instead maintains basal 
tone. This is an energy efficient state as cross-bridges are 
maintained (19).
Transforming growth factor-β (TGFB) is an important 
cytokine that has a vital role in the development and 
maintenance of the vascular extracellular matrix. TGFB 
is generally secreted in its inactive form where it is 
anchored with fibrillin-1 to form a large latent complex. 
Microfibrils (mainly fibrillin-1) regulate the bioavailability 
and local activity of TGFB. Activated TGFB stimulates the 
phosphorylation of receptor-regulated Smad protein, 
which regulates transcription of genes responsible for 
extracellular matrix synthesis and stabilisation. TGFB 
signalling has also been associated with extracellular 
matrix degradation through the upregulation of 
metalloproteinase-2 and metalloproteinase-9. Recent 
evidence has shown that TGFB appears to have a greater role 
in extracellular matrix synthesis compared to degradation. 
Furthermore, the pathways involving extracellular matrix 
degradation through metalloproteinase-2 have also 
been shown to promote extracellular matrix synthesis. 
Shen  et  al. identified a dual role of metalloproteinase-2 
in mice and also showed increased susceptibility to TAA 
due to metalloproteinase-2 deficiency (20). This shows 
that TGFB is essential in maintaining extracellular matrix 
stability and the defects in this signalling pathway are 
most prominent in the thoracic aorta as it has the greatest 
amount of extracellular matrix. However, dysregulation 
of TGFB signalling had divergent results, with both a 
protective and harmful role demonstrated in thoracic 
aorta pathology. Increased levels of TGFB have been 
associated with aggravating thoracic aorta pathology, as 
direct neutralization of TGF-B using antibodies showed 
reduced dilation in the ascending aorta (21). Interestingly, 
TGFB appears to exert different roles in the different cell 
types. Angelov  et  al. demonstrated that smooth muscle 
specific but not systemic inhibition of TGFB significantly 
increased the risk of TAA in angiotensin-II infused mice 
(22). This suggests that smooth muscle cell TGFB provide 
a protective effect on the vessel wall, and this action is 
possibly due to the previously established role of TGFB to 
stimulate VSMC proliferation (23).
Mechanics of the thoracic aorta
In order to understand the physical factors that lead to 
the formation of TAAD, it is important to understand 
mechanics of the thoracic aorta in health. Aortic tissue 
has several key physical properties that allow it to 
accommodate the pressures relayed through ventricular 
systole.
First, it has a non-linear stress–strain relationship at 
higher load levels, possibly mediated by collagen fibres 
(Fig. 2). Lower load levels demonstrate a nearly linear 
relationship between these two domains, mediated by 
elastin (24). Stress can be within the longitudinal or circular 
axis. There has been an observed difference in longitudinal 
stress along the path of the thoracic aorta, highest around 
the aortic arch and declining along the descending aorta. 
Secondly, aortic tissue has been demonstrated to increase 
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in stiffness with increasing load. These properties may be 
exerted due to glycosaminoglycans (GAG), as research 
in porcine tissue treated with GAG removal showed 
quicker rates of stiffening in response to escalating load 
(25). Tissue from the thoracic aorta is pseudoelastic, 
in that there are different stress–strain patterns during 
loading and unloading. The difference can be reduced by 
repeating this process (i.e. conditioning tissue), however, 
it is suggested that this property is not demonstrated by 
human aortic tissue in vivo (26).
Aneurysmal tissue has several physical properties 
that are different to healthy aortic tissue. It has been 
demonstrated that aneurysmal specimens are stiffer 
in the longitudinal and circumferential dimensions 
compared to controls (27), however, this is inconsistent 
across the evidence base (28, 29). Strength and stiffness 
may be more pronounced circumferentially (29), possibly 
associated with increased deposition of collagen fibres 
in this direction (30). It is also suggested that there is 
concomitant decrease in elastin (31).
Physical forces aside from longitudinal and 
circumferential stress may play a part in aortic tissue 
remodelling. Combining ex vivo data with computational 
models, Witzenburg et al. demonstrated very low strength 
of porcine ascending aortas to radial shear, particularly in 
response to repeated loading (32). This could suggest an 
overlooked aspect of dissection.
Ability of the aorta to store and deploy energy is key to 
transmitting pressure from the left ventricle and driving 
perfusion to tissues. This property can be examined 
through tensile testing. Evidence suggests that a quick 
rate of energy loss is associated with failure of aortic tissue 
to withstand stress, predisposing it to dissection and 
aneurysms (33). The content and orientation of elastin in 
murine aortic tissue was found to be a strong predictor 
of energy storage (34). However, this finding was not 
replicated in a study comparing diseased murine tissue to 
controls (35).
The best example of these processes in action involve 
aneurysms caused by bicuspid aortic valve disease. 
Bicuspid valves differ from their counterparts with regard 
to number of leaflets (two vs three) and annular geometry 
(oval vs circular) (36). These alterations can lead to uneven 
sheer stress of systolic blood flow, which predisposes to 
aortic dilation and aneurysm formation at the root (37).
While ex vivo testing provides important information 
and context to link biological components with 
mechanical properties, inconsistencies in the evidence 
base suggest multiple factors may be responsible 
for aortic tissue failure. Furthermore, in vivo testing 
combined with computational fluid dynamics may 
be more beneficial for risk stratification and clinical 
decision making.
Genetic predisposition to thoracic 
aorta disease
TAA and TAD can be caused by syndromic and non-
syndromic genetic factors. 
Genetic syndromes
Marfan syndrome (MFS) is an autosomal dominant 
connective tissues disorder caused by mutations in the 
FBN1 gene, which codes for fibrillin-1. Fibrillin-1 is a 
significant component of the extracellular matrix, hence 
Marfan’s syndrome has been associated with an increased 
risk in thoracic aortic disease. Furthermore, deficiency in 
fibrillin-1 leads to the dysregulation of TGFB expression, 
which was thought to be the cause of thoracic aorta 
malformation. However, as described earlier the precise 
role of TGFB is controversial, and Marfan’s syndrome 
has not been associated with an increased expression 
of bioactive TGFB (38). Nolasca  et al. recently identified 
another potential mechanism to explain the impaired 
smooth muscle force observed in Marfan’s syndrome 
(39). Furthermore, VSMC of MFS mice demonstrated 
a phenotype switch to mesenchymal-like cells, which 
Figure 2
Stress–strain relationships in the thoracic aorta. The solid line depicts the 
natural relationship modelled in vivo. The dotted line depicts the 
relationship when collagen content is reduced.
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
https://doi.org/10.1530/VB-20-0015
S Iddawela, A Ravendren 
et al.
Pathological basis of thoracic 
aortic disease
R293:1
resulted in impaired traction forces and a dampened force 
response to stiffer substrates (39). This further affirms 
the plasticity of the cells in the thoracic wall and its 
contributions to vascular disease. 
Vascular Ehlers–Danlos syndrome (EDS) is another 
connective tissue disorder commonly associated with 
thoracic aorta disease. EDS type IV is an autosomal 
dominant pathology that is caused by a defective type 
III procollagen gene (COL3A1) that primarily affects the 
ECM of the heart and vasculature (40). Type III collagen 
predominates in the tunica adventitia, hence defective 
synthesis leads to increased fragility of the vessel, which is 
most prominent in the thoracic aorta. MRI measurements 
of the ascending aorta of EDS patients revealed a small 
incidence of enlarged ascending aortas without the 
formation of aortic aneurysms (41). Overall, the mutant 
type III collagen reduces stiffness of the adventitia and 
leads to widening of the aorta. 
Loey–Dietz syndrome (LDS) is an autosomal 
dominant connective tissue disease that shares features 
with MFS and EDS. There are five types (types 1–5), caused 
by mutations in TGFBR1, TGFBR2, SMAD3, TGFB2 and 
TGFB3, respectively (42). Although autosomal dominant, 
at least 75% of patients have a de novo mutation and 
are the first in their family to manifest the disease (42). 
These mutations interfere with cell signalling pathways 
modulated by TGFB (discussed earlier). Patients with LDS 
present with aneurysms of the aorta which are particularly 
susceptible to dissection and the only available therapy is 
surgical treatment and regular surveillance. 
Non-syndromic genetic predisposition
Non-syndromic causes of TAAD are confined to the aorta 
and do not have other systemic abnormalities. Non-
syndromic causes account for 95% of all TAADs and can 
be further subdivided into familial and non-familial (also 
known as sporadic) (43). Familial non-syndromic TAADs 
refers to the instance when one or more family member 
is also diagnosed with TAAD (44). Research continues 
to identify genetic causes of familial TAADs, as 21% of 
patients have a positive family history of the condition. 
Interestingly, 21% appears to be an underestimate as many 
family members do not undergo the routine imaging to 
identify non-symptomatic aneurysms (43). In contrast, 
it was previously thought that sporadic non-syndromic 
TAADs are solely degenerative mediated. However, recent 
research suggests that there is also an underlying genetic 
cause in sporadic non-syndromic TAADs most likely due 
to variably penetrant gene expression (45).
ACTA2 encodes an isoform specific to SMC of 
α-actin, which polymerises to form thin filaments of the 
contractile unit. Mutations in ACTA2 disrupts the amino 
acid arrangement in the subdomains of the actin, which 
alters the gross structure of the actin monomer. This 
leads to dysfunctional contraction of SMCs, manifesting 
as multisystemic smooth muscle dysfunction syndrome, 
which contributes to the pathogenesis of TAAD (40). 
Furthermore, Lu et al. demonstrated that the structurally 
altered actin monomer showed impaired interaction 
with myosin, unstable filament formations and an 
increase the number of actin monomer (46). The multiple 
defects observed suggest that mutant actin will decrease 
contractility of SMC in response to pulse pressure. Hence, 
ACTA2 mutations have the most pronounced effect in 
the thoracic aorta which is sensitive to pulse pressure and 
requires a highly responsive vessel wall. 
Multifactorial origin of thoracic 
aortic disease
There is a complex interplay between biological, 
mechanical and genetic factors that may cause thoracic 
aortic disease. The composition of aortic tissue provides it 
with inherent physical factors that allow it to accommodate 
and transmit pressures from the left ventricular outflow 
tract and maintain perfusion to the whole body. This is 
governed by chemical signalling and the function of these 
proteins are influenced by genetic factors. 
Stress across aortic walls is conventionally thought 
to be exerted longitudinally and circumferentially. The 
relationship has been demonstrated to be non-linear, 
particularly at higher load levels. Longitudinal stress 
may differ more markedly than circumferential along 
the course of the thoracic aorta, and this is related to 
the reduction in elastin deposition along its length. The 
orientation of collagen fibres may also play an important 
role in stiffness and the stress–strain relationship of aortic 
tissue. Genetic disorders such as EDS interfere with the 
synthesis of collagen, which affects the ability of the 
thoracic aorta to withstand large pressures and predispose 
it to aneurysms and dissections due to wall weakness. 
SMC play an integral role in the dynamic response 
to change in pressures within the thoracic aorta and they 
are sensitive to neural input. Modulating the stress–strain 
relationship, loading and unloading is critical to ensure 
integrity of the vessel and maintain perfusion. Mutations 
in components such as actin and myosin have been 
demonstrated in vivo to reduce contractility of these cells. 
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The factors governing genetic syndromes such as abnormal 
elastin, tone and signalling can lead to maladaptive 
mechanotransduction which ultimately lead to a failure in 
aortic tissue to cope with wall stress. Since the genetic basis 
of TAAD is poorly understood, there are likely numerous 
genetic defects that affect smooth muscle cells, collagen 
and elastin to alter the strength and durability of tissue.
Most studies investigating thoracic aorta physiology 
usually analyse only one factor such as cell phenotype, 
which makes examining the interplay between all bio-
chemo-mechanical factors difficult. However, there are a 
few experiments which have studied at least two factors 
and provide some insight on the combined effect of 
these factors. For example, Yamashiro et al. analysed solid 
mechanics in the context of extracellular matrix changes 
and determined that loss of elastic fibres in the thoracic 
wall leads to dysfunction in the mechanosensing of SMC 
(47). Atkins  et  al. investigated the effect of disruption 
in haemodynamics and its influence on the structure 
of the vessel wall. The porcine models demonstrated 
that disruptions in fluid dynamics influence chemical 
pathways, such as metalloproteinase 2, and directly 
mediatemedial degradation which contributes to TAA 
formation (48). These limited studies provide an insight 
on how the bio-chemo-mechanics factor are vital in 
normal physiology and that disruption in one can affect 
other factors and contribute to disease. 
It is worth noting that the most prominent risk 
factor noted in patients with aneurysm or dissection is 
hypertension, highlighting the influence of lifestyle factors 
and interplay with biological and mechanical factors that 
affect integrity of the aorta. Bersi  et  al. examined the 
extracellular matrix and biomechanical difference of the 
thoracic aorta in hypertensive mice models to understand 
the varying susceptibility to disease in different sections 
of the aorta (49). The hypertensive models demonstrated 
disrupted intrinsic material stiffness in the intra mural 
cells of the ascending aorta, which leads to aneurysmal 
dilation. Additionally, the descending aorta showed 
excess fibrosis due to mechanical stress-initiated and 
inflammation-driven remodelling. 
Screening programmes
There are no formal screening programmes for TAAs, 
possibly due to relative infrequency. A systematic review 
examined the evidence on the utility of screening for 
TAA in patients with giant cell arteritis. They reported 
significantly increased risk in these patients compared 
to controls. However, up to 5–10 patients would need 
imaging to detect a previously unknown aneurysm or 
dissection (50). Research investigating the value of genetic 
screening in patients with TAA or TAD found nearly a 
quarter had mutations of unknown significance in the 21 
gene panel set (48).
Screening programmes may be of limited clinical 
utility in the general population but may be of use in 
at-risk patients. Additionally, deciding on an appropriate 
modality that is sensitive, specific and cost-effective is 
crucial to the success of any prospective programme. 
Commonly used imaging techniques (such as ultrasound) 
could be employed to track the strain in TAAs and aortic 
tissue stiffness, which have been subsequently validated 
(49, 50). Emerging technologies include 4D ultrasound, 
which can estimate strain using time-resolved 3D images. 
They have been used to good effect in estimating animal 
aortic aneurysm strain (51). Further research is needed 
to ensure an accessible, sensitive technique is chosen to 
enable creation of a feasible screening programme. 
A major issue faced by clinicians in the management of 
TAAD is the capacity to determine which patient with an 
aneurysm will dissect or rupture. Currently, aortic diameter 
is measured to predict the aneurysm risk, however, it fails 
to detect all potential TAADs even in patient with a family 
history of TAAD (52). This emphasizes the need to find new 
biomarkers to help stratify risk in patients with a TAA. A 
recent study identified that elevated and persistent levels 
CRP, IL6 and TNF were as associated with progression of 
TAAD. The changing pattern of CRP could potentially be 
used as a marker of diagnosis and prophylactic treatment 
of complications (53).
Future research
There is a plethora of studies exploring one factor to 
assess its mechanism on the context of the thoracic 
aorta. Future studies should aim to combine the results of 
different experiments in a multifactorial computational 
model to assess the bio-chemo-mechanics of the thoracic 
aorta. Current studies only usually only focus on one 
factor, such as mechanics or biology and do not provide 
insight on how they rely on each other and contribute 
towards the pathological mechanism of thoracic disease. 
Additionally, bio-chemo-mechanical role of other 
components of the thoracic aorta also require further 
attention. For example, the role of proteoglycan in disease 
progression in the thoracic aorta is unclear and warrants 
further investigation, as they appear to be important in 
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the signalling pathways of the thoracic aorta (50). TGFB 
is another yet controversial cytokine as its signalling 
pathway in disease has provided divergent results. Hence, 
future research should also aim to use more robust 
methods to investigate the role of TGFB. For example, 
many studies in the past have used pSmad 2 as a surrogate 
marker of TGFB. However, this has its own caveats as 
other pathways independent of TGFB have also shown 
to activate SMAD2 (36). Therefore, careful experimental 
designs and objective interpretation are required for 
future studies to tackle the wide range of disparities. 
At present, clinical prediction of the risk of aneurysmal 
rupture is confined to aortic diameter. This metric is 
unreliable and shows great variation between individuals, 
therefore there is a need to determine biomarkers that are 
correlated with aneurysmal growth and risk of rupture. 
This will allow appropriate risk factor stratification and 
more accurate clinical decision making. 
Summary and conclusion
Thoracic aortic aneurysms and dissections are serious 
albeit rare diseases that can result in high mortality if not 
detected and managed appropriately. The pathophysiology 
is poorly understood and has several factors in play. 
Smooth muscle cells and the composition of collagen 
and elastin helps mediate key mechanical properties that 
allow the thoracic aorta to withstand and transmit large 
pressures, however, remodelling is poor and dysfunctional 
processes can lead to tissue failure. Genetic syndromes 
can lead to defects in signalling proteins responsible for 
muscle contraction or connective tissue composition, 
thereby leading to inherent weakness. The impact of 
hypertension (which has genetic and environmental 
influences) is considerable in development of TAA and 
TADs, highlighting the need for research that considers 
multiple factors in studying pathophysiology. 
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